EVIDENCE. A CURATED READING LIST
Clinical studies and active trials from PubMed and ClinicalTrials.gov, surfaced quietly, organized by topic, linked back to source. EVORA does not write opinion essays. We keep a reading list, the way a thoughtful clinician would, and revisit it as the evidence moves.
1906 studies indexed.
MOST RECENT. ACROSS THE LITERATURE
GLP-1 · 2026 · PRACTICE GUIDELINE · 113 CITATIONS · PMID 41324410
World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults. Celletti F(1), Farrar J(2), De Regil L(3). IMPORTANCE: Obesity is a chronic, relapsing disease affecting over 1 billion people worldwide,…
MORE FROM THE LITERATURE
Further studies in active rotation, ranked by editorial weight, not recency alone.
Peptides, 2026, Practice Guideline
Semaglutide therapy for metabolic dysfunction-associated steatohepatitis: November 2025 updates to AASLD Practice Guidance. Bansal MB(1), Patton H(2)(3), Morgan TR(4)(5), Carr RM(6), Dranoff JA(7)(8), Allen AM(9). This practice recommendation serves as an update to the 2023…
Sleep, 2026, Practice Guideline
ERS/EULAR clinical practice guidelines for connective tissue disease-associated interstitial lung disease developed by the task force for connective tissue disease-associated interstitial lung disease of the European Respiratory Society (ERS) and the European Alliance of…
Hormones, 2026, Practice Guideline
Diagnosis and Management of Community-acquired Pneumonia: An Official American Thoracic Society Clinical Practice Guideline. Jones BE, Ramirez JA, Oren E, Soni NJ, Sullivan LR, Restrepo MI, Musher DM, Erstad BL, Pickens C, Vaughn VM, Helgeson SA, Crothers K, Metlay JP, Bissell…
Peptides, 2026, Practice Guideline
Kidney Disease and Heart Failure: Recent Advances and Current Challenges: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Lam CSP(1), Bozkurt B(2), Cherney DZI(3), Ezekowitz JA(4), Jardine MJ(5), Khan SS(6), Madero M(7), Sarnak…
Peptides, 2026, Practice Guideline
Kidney disease and heart failure: recent advances and current challenges: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Lam CSP(1), Bozkurt B(2), Cherney DZI(3), Ezekowitz JA(4), Jardine MJ(5), Khan SS(6), Madero M(7), Sarnak…
Inflammation, 2026, Meta-Analysis
Mediterranean Diet Reduces Inflammation in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Keshani M(1), Rafiee S(1), Heidari H(1), Rouhani MH(1), Sharma M(2)(3), Bagherniya M(1). CONTEXT: Inflammation and oxidative stress play pivotal roles in the…
GLP-1, 2026, Comparative Study
Who Wins the Battle Against Obesity? A Network Meta-Analysis Comparing Tirzepatide and Semaglutide. Bernardi JC(1), Cavalcante DVS(2), Huntermann R(1), Molinari ME(1), Zanon LZ(1), Khater J(3), Gomez VA(4), Fischer-Bacca CO(1). INTRODUCTION: Pharmacological therapies are…
STUDIES IN MOTION
Trials currently recruiting across the topics we follow, the science is still moving.
Source · ClinicalTrials.gov
Loading…
EVIDENCE LEDGER
SOURCED · PUBMED · CLINICALTRIALS.GOV
STUDIES INDEXED
1,000
TOPICS IN ROTATION
23
ACTIVE TRIALS
—
LAST REFRESH
—
We index real citations and active trials, never opinion essays, never fabricated authors. Studies are weighted by editorial score: design quality, sample size, recency, and how directly they speak to the topics our members are reading against.
Field Notes · Subscribe
One Field Note in your inbox when it ships. No marketing, no digest, no schedule pressure. Unsubscribe in one click.
